COMMODORE CAPITAL LP VRDN Holdings History
COMMODORE CAPITAL LP's Viridian Therapeutics Inc Holding Summary
As of 2025-03-31, COMMODORE CAPITAL LP held 3.60 Mil shares of Viridian Therapeutics Inc(VRDN), totaling $48.53 Mil. This investment constitutes 3.58% of their stock portfolio, and COMMODORE CAPITAL LP now holds 4.41% of the outstanding Viridian Therapeutics Inc(VRDN) stock.
The initial trade took place in 2021Q1. And since then COMMODORE CAPITAL LP has made 14 purchases of VRDN, at an average price of $16.20, for a total of 5.40 Mil shares. In addition, there have been 3 sales at an average price of $21.04 for 1.10 Mil shares. Based on historical transaction data and VRDN's current price of $18.21, COMMODORE CAPITAL LP's estimated gain on his VRDN holdings is $13.97 Mil, reflecting a 15.96% gain to date.
COMMODORE CAPITAL LP VRDN ($18.21) Holding Chart
COMMODORE CAPITAL LP VRDN ($18.21) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1